Trials / Withdrawn
WithdrawnNCT02120755
A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Liventa Bioscience · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This research project is testing a product called AmnioClear™ which is an amniotic membrane graft processed for Liventa Bioscience formerly AFCell Medical. AmnioClear™ allograft human amniotic membrane is regulated solely under section 361 of the Public Health Service Act. The purpose of the study is to see if this treatment works to accelerate the healing time of chronic wounds.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | AmnioClear™ Human Allograft Amniotic Membrane |
Timeline
- Primary completion
- 2014-10-01
- First posted
- 2014-04-23
- Last updated
- 2016-03-03
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02120755. Inclusion in this directory is not an endorsement.